Pharmaco (Merseyside) Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 10103359

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Investments	4		2,248,796		2,248,796

			2,248,796		2,248,796
CURRENT ASSETS
Debtors	5	978		2,152

		978		2,152
NET CURRENT ASSETS (LIABILITIES)			978		2,152

TOTAL ASSETS LESS CURRENT LIABILITIES			2,249,774		2,250,948

NET ASSETS			2,249,774		2,250,948

CAPITAL AND RESERVES
Called up share capital			1,250		1,250
Profit and Loss Account			2,248,524		2,249,698

SHAREHOLDERS' FUNDS			2,249,774		2,250,948

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Mitul Patel

Director

21 July 2026

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Pharmaco (Merseyside) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10103359 . The registered office is 205 Plumstead Road, Norwich, Norfolk, NR1 4AB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 3 (2024: 3)

4. Investments

	Subsidiaries
	£
Cost or Valuation
As at 1 December 2024	2,248,796

As at 30 November 2025	2,248,796

Provision
As at 1 December 2024	-

As at 30 November 2025	-

Net Book Value
As at 30 November 2025	2,248,796

As at 1 December 2024	2,248,796

Details of investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking Holding Proporation of voting rights &shares

Subsidiary undertakings

Paxton Limited Ordinary shares 100%

Registered office

205 Plumstead Road, Norwich, Norfolk, United Kingdom, NR1 4AB

The principal activity of Paxton Limited is supply medicines and other goods as a pharmacy.

The profit for the financial period of Paxton Limited was £676,104 and the aggregate amount of capital and reserves at the end of the period was £388,377.

5. Debtors

	2025	2024
	£	£
Due within one year
Other debtors	978	2,152

Page 2

Page 3

Pharmaco (Merseyside) Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 November 2025

6. Related Party Transactions

Mr Harshad Patel, Mrs Divya Patel and Mr Mitul Patel are directors of the company. At the end of the year amount owed by the company to the directors is £0.00 (2024: £0.00).

During the year, the company has declared dividend of £0.00 (2024: £0.00).

7. Summary of transactions with subsidiaries

Summary of transactions with subsidiaries

Paxton Limited

(100% subsidiary undertaking of the Pharmaco (Merseyside) Limited)

Paxton Limited has given a cross guarantee towards the company's bank borrowings supported by a debenture created on 8 August 2019 and a legal charge over the leasehold property Paxton Limited trades from.

At the balance sheet date the amount Owed by Paxton Limited was £0.00 ( 2024 :£0.00 ). The loan is interest free and repayable on demand.

Page 3